Actively Recruiting
Textbook Outcomes of Right Hemihepatectomy in Patients With Hepatocellular Carcinoma
Led by West China Hospital · Updated on 2025-04-30
400
Participants Needed
1
Research Sites
5 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Although traditional open right hemihepatectomy is a mature technique, the incision is usually very large; Intraoperative bleeding may be excessive, and postoperative liver failure is also prone to occur. In recent years, compared with traditional open surgery, laparoscopic surgery has many advantages, such as smaller surgical incision and faster postoperative recovery. In recent years, more and more centers have gradually transitioned to performing right hemihepatectomy through laparoscopy as much as possible. However, due to the difficulty of the surgery, steep learning curve, and postoperative complications, its adoption is limited to high-capacity surgical centers. Despite significant progress in laparoscopic liver resection technology, its clinical efficacy remains controversial, especially in laparoscopic right hemihepatectomy. More research is needed to confirm the feasibility and safety of this surgery. At present, it is unclear whether there is a difference in textbook outcomes (TO) between HCC patients undergoing open and laparoscopic right hemihepatectomy, and the association between TO and patient survival prognosis.
CONDITIONS
Official Title
Textbook Outcomes of Right Hemihepatectomy in Patients With Hepatocellular Carcinoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Lesion limited to the right half of the liver diagnosed as hepatocellular carcinoma by pathology and immunohistochemistry
- Scheduled for elective right hemihepatectomy surgery
- Preoperative liver function classified as Child Pugh A or B
- Preoperative ASA rating of I, II, or III
You will not qualify if you...
- Confirmed cholangiocarcinoma, mixed cell carcinoma, or extrahepatic metastatic malignant tumors
- Previous upper abdominal surgery
- Concurrent resection of adjacent abdominal organs or major vessel and biliary reconstruction surgery except gallbladder
- Invasion of adjacent organs (other than gallbladder), main blood vessels, bile duct cancer emboli, or distant metastases
- Lost to follow-up or missing primary clinical data
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
West China Hospital
Chengdu, Sichuan, China, 610041
Actively Recruiting
Research Team
J
Jiwei Huang Professor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here